Curavac
Phase 2For a world without autoimmune diseases Targeted Active Therapies and Active Targeted Immunotherapies Learn more Who we are CuraVac is a clinical-stage biotechnology company developing Targeted Active Therapy and Active Targeted Immunotherapies for autoimmune diseases. With the use of a new revolutionary technique based on complementary peptides, we aim to treat and to induce long-term immunity against autoimmune … Home Read More »
About
For a world without autoimmune diseases Targeted Active Therapies and Active Targeted Immunotherapies Learn more Who we are CuraVac is a clinical-stage biotechnology company developing Targeted Active Therapy and Active Targeted Immunotherapies for autoimmune diseases. With the use of a new revolutionary technique based on complementary peptides, we aim to treat and to induce long-term immunity against autoimmune … Home Read More »
Funding History
2Total raised: $5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile